sales@starshinechemical.com
CAS RN: 755037-03-7
Regorafenib
- Product code: ICTR0142
- Purity/Analytical Methods: >98.0%(HPLC)
Basic Information
| Appearance and Shape (20°C) | Solid |
|---|---|
| CAS RN | 755037-03-7 |
| MDL number | MFCD16038047 |
| Molecular weight | 482.82 |
| Molecular Formula | C21H15ClF4N4O3 |
| Product code | ICTR0142 |
| PubChem Substance ID | 354334233 |
| Purity/Analytical Methods | >98.0%(HPLC) |
| Reaxys-RN | 14359949 |
| Situations to avoid | Heat Sensitive |
Technical Specifications
Technical Specifications
| Appearance | White to Light yellow to Light orange powder to crystal |
|---|
Safety and Regulatory
GHS
| Pictograms |
|
|---|---|
| Hazard statement | H302 : Harmful if swallowed H361 : Suspected of damaging fertility or the unborn child H373 : May cause damage to organs through prolonged or repeated exposure. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant P260 : Do not breathe dust/ fume/ gas/ mist/ vapors/ spray P270 : Do not eat, drink or smoke when using this product P202 : Do not handle until all safety precautions have been read and understood P201 : Obtain special instructions before use P264 : Wash skin thoroughly after handling P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection P308 + P313 : IF exposed or concerned: Get medical advice/ attention P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth P405 : Store locked up. |
| Signal word | Warning |
Product Category
Chemical structure
Life Science Biochemicals and Reagents Enzymes, Enzyme Inhibitors, Enzyme Substrates Enzyme Inhibitors [Biochemicals and Reagents] Enzyme Inhibitors [P to Q] Protein Kinase Inhibitors, Tyrosine Enzyme Inhibitors by Enzyme Pharmaceutical Ingredients (for Research and Experimental Use) Antitumor Ingredients (for Research and Experimental Use) Antitumor Molecular Target Inhibitors Cell Biology Cancer Research Angiogenesis Angiogenesis Inhibitors Antitumor Agents Receptor Tyrosine Kinase (RTK) Inhibitors Fibroblast Growth Factor Receptor (FGFR) Family Kinase Inhibitors Platelet Derived Growth Factor Receptor (PDGFR) Family Kinase Inhibitors Rearranged During Transfection (RET) Kinase Inhibitors Tyrosine Kinase with Immunoglobulin-like and EGF-like Domains (TIE) Family Kinase Inhibitors Vascular Endothelial Growth Factor Receptor (VEGFR) Family Kinase Inhibitors Tyrosine Kinase Inhibitors [Antitumor Agents] Cell Signaling and Neuroscience Kinase/Phosphatase Biology Fibroblast Growth Factor Receptor (FGFR) Family Kinase Inhibitors Platelet Derived Growth Factor Receptor (PDGFR) Family Kinase Inhibitors Rearranged During Transfection (RET) Kinase Inhibitors Tyrosine Kinase with Immunoglobulin-like and EGF-like Domains (TIE) Family Kinase Inhibitors Vascular Endothelial Growth Factor Receptor (VEGFR) Family Kinase Inhibitors Receptor Tyrosine Kinase (RTK) Inhibitors Pharmaceutical Development and Drug Discovery Research Pharmaceutical Ingredients (for Research and Experimental Use) Antitumor Ingredients (for Research and Experimental Use) Antitumor Molecular Target Inhibitors